10x Genomics Partners with Brigham & Women's Hospital to Advance Blood-Based Autoimmune Diagnostics

Reuters01-12
<a href="https://laohu8.com/S/TXG">10x Genomics</a> Partners with Brigham & Women's Hospital to Advance Blood-Based Autoimmune Diagnostics

10x Genomics Inc. has announced a collaboration with Brigham & Women’s Hospital to advance research in blood-based diagnostics for autoimmune diseases. The partnership will focus on analyzing peripheral blood samples from patients with rheumatoid arthritis, systemic lupus erythematosus, and giant cell arteritis, aiming to identify single-cell immune signatures associated with disease activity, flares, remission, and treatment responses. The joint effort also includes developing a framework for future clinical reports, translating molecular features into actionable insights to support physicians in managing autoimmune diseases. This initiative is part of 10x Genomics’ broader strategy to leverage single-cell and spatial technologies for improved patient care and personalized medicine in rheumatology.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA60594) on January 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment